CFH and age-related macular degeneration: We observed within both study groups that individuals who carry the AMD-associated CFH risk haplotype had higher plasma concentrations of complement activation products, and conversely that protective CFH haplotypes were associated with lower levels of activation products (p = 0.05, MANOVA).